Get the app
US › Consumer Defensive

Niagen Bioscience, Inc. (NAGE)

US · Consumer Defensive · Packaged Foods

$2.07-1.66%
Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue
$29.8M
Revenue YoY
-4.3%
Net profit
$963,000
Profit YoY
-73.3%
EPS
$0.01
EPS estimate
$0.01
Net margin
3.2%

EPS came in at 0.01 against a street estimate of 0.01 — a beat of 0.0%.

Key statistics

Market cap
$199.4M
P/E
13.3
Forward P/E
16.9
P/B
2.26
Book value
$1.04
EPS (TTM)
$0.19
52-week high
$7.28
52-week low
$2.05
50-day MA
$2.83
200-day MA
$3.88
Beta
2.08

Analyst view

Analysts rate Niagen Bioscience, Inc. a strong buy (6 buy, 0 hold, 0 sell out of 6) with an average price target of $11.92.

Shareholding

Insiders
29.45%
Institutions
41.60%

Largest institutional holders

FundStake
BlackRock Inc5.29%
Steel Peak Wealth Management LLC4.42%
Vanguard Capital Management, LLC2.71%
Tieton Capital Management, LLC2.54%
Qube Research & Technologies2.05%
Geode Capital Management, LLC1.87%
UBS Group AG1.62%
The Goldman Sachs Group Inc1.60%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Niagen Bioscience, Inc. — free to start.

Open in the appGoogle PlayApp Store

Other Consumer Defensive companies

Walmart Inc.Costco Wholesale CorpThe Coca-Cola CompanyProcter & Gamble CompanyPhilip Morris International IncPepsiCo IncAnheuser Busch Inbev NV ADRUnilever PLC ADRBritish American Tobacco p.l.c.Altria GroupMonster Beverage CorpMondelez International Inc

Data updated 2026-11-07.